Feedback (GB:FDBK) has released an update.
Feedback PLC has entered into a collaboration agreement to enhance NHS diagnostic processes by integrating their Bleepa technology with community diagnostics, potentially redirecting 190 million tests annually to pharmacies. The partnership aims to reduce patient wait times and improve the referral system, with a pilot program already in progress to validate the benefits of this initiative. The success of this model could lead to significant national and international market opportunities, contributing to a more efficient healthcare system.
For further insights into GB:FDBK stock, check out TipRanks’ Stock Analysis page.